Fig. 5From: Almonertinib-induced interstitial lung disease in a lung adenocarcinoma patient complicated with interstitial lung abnormalitya–c Thirty-five days after glucocorticoid treatment, chest CT (July 9, 2021) on outpatient follow-up showed a significant reduction in interstitial inflammation than beforeBack to article page